Research output per year
Research output per year
Personal profile
External positions
Honorary Associate Professor, Univ Exeter, University of Exeter, Exeter Med Sch
2014 → 2017
Visiting Professor, Univ Alberta, University of Alberta
1-Oct-2013 → 31-Dec-2013
Visiting Professor, Harbin Med Univ, Harbin Medical University, Affiliated Hosp 1, Dept Hematol
2012 → …
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The DNA damage response pathway regulates the expression of the immune checkpoint CD47
Ghantous, L., Volman, Y., Hefez, R., Wald, O., Stern, E., Friehmann, T., Chajut, A., Bremer, E., Elhalel, M. D. & Rachmilewitz, J., Dec-2023, In: Communications biology. 6, 10 p., 245.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
Freile, J. Á., Ustyanovska Avtenyuk, N., Corrales, M. G., Lourens, H. J., Huls, G., van Meerten, T., Cendrowicz, E. & Bremer, E., 19-May-2022, In: Biomedicines. 10, 5, 19 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Citations (Scopus)35 Downloads (Pure) -
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
Medler, J., Kucka, K., Melo, V., Zhang, T., von Rotenhan, S., Ulrich, J., Bremer, E., Hudecek, M., Beilhack, A. & Wajant, H., 2022, In: Theranostics. 12, 4, p. 1486-1499 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)19 Downloads (Pure) -
CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies
Bouwstra, R., van Meerten, T. & Bremer, E., Aug-2022, In: Clinical and Translational Medicine. 12, 8, 25 p., e943.Research output: Contribution to journal › Review article › peer-review
Open AccessFile68 Downloads (Pure) -
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Cendrowicz, E., Jacob, L., Greenwald, S., Tamir, A., Pecker, I., Tabakman, R., Ghantous, L., Tamir, L., Kahn, R., Avichzer, J., Aronin, A., Amsili, S., Zorde-Khvalevsky, E., Gozlan, Y., Vlaming, M., Huls, G., van Meerten, T., Dranitzki, M. E., Foley-Comer, A., Pereg, Y., & 3 others, 14-Mar-2022, In: Journal of experimental & clinical cancer research. 41, 16 p., 97.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile8 Citations (Scopus)20 Downloads (Pure)
Activities
-
R. Bouwstra; Innate immune checkpoint inhibitors for treatment of diffuse large B-cell lymphoma
Jon Daniel Laman (Member of PhD Examining Committee), Edwin Bremer (Supervisor), Gerwin Huls (Supervisor) & Tom van Meerten (Co-supervisor)
21-Sept-2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
The 62nd American Society of Hematology (ASH)
Edwin Bremer (Invited speaker)
5-Dec-2020Activity: Talk and presentation › Academic presentation › Academic
-
Cancers (Journal)
Edwin Bremer (Editorial board member)
2020 → …Activity: Peer-review and editorial work › Editorial work › Academic
-
Kahr Med (External organisation)
Edwin Bremer (Member of board)
Mar-2018 → …Activity: Membership › Academic
-
Consultant for Kahr Medical
Edwin Bremer (Consultant)
2016 → …Activity: External assignment › Consultancy › Professional
Datasets
-
Additional file 1 of DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Tabakman, R. (Contributor), Cendrowicz, E. (Contributor), Pecker, I. (Contributor), Gozlan, Y. (Contributor), Kahn, R. (Contributor), Dranitzki, M. E. (Contributor), Tamir, A. (Contributor), Tamir, L. (Contributor), Jacob, L. (Contributor), van Meerten, T. (Contributor), Avichzer, J. (Contributor), Peled, A. (Contributor), Aronin, A. (Contributor), Amsili, S. (Contributor), Vlaming, M. (Contributor), Huls, G. (Contributor), Foley-Comer, A. (Contributor), Chajut, A. (Contributor), Zorde-Khvalevsky, E. (Contributor), Pereg, Y. (Contributor), Greenwald, S. (Contributor), Ghantous, L. (Contributor) & Bremer, E. (Contributor), figshare Academic Research System, 15-Mar-2022
DOI: 10.6084/m9.figshare.19359964.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_DSP107_combines_inhibition_of_CD47_SIRP_axis_with_activation_of_4-1BB_to_trigger_anticancer_immunity/19359964/1
Dataset
Press/Media
-
2,6 miljoen subsidie voor revolutionair oncologie onderzoek
04/08/2022
1 Media contribution
Press/Media: Other › Popular
-
UMCG in Groningen krijgt Europese miljoenensubsidie voor onderzoek naar nieuwe vorm van immuuntherapie bij kanker
02/08/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
UMCG ontvangt grote EU-subsidie voor onderzoek naar nieuwe immuuntherapie bij kanker
02/08/2022
3 Media contributions
Press/Media: Public Engagement Activities › Popular
-
Miljoenensubsidie voor UMCG-onderzoek naar therapie voor uitbehandelde kankerpatiënten
02/08/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Grote EU-subsidie voor UMCG voor onderzoek naar CAR-T immuuntherapie bij kanker
02/08/2022
1 Media contribution
Press/Media: Public Engagement Activities › Popular
Prizes
-
-
-
-
Alexander von Humboldt Fellowship
Bremer, Edwin (Recipient), 2007
Prize: Fellowship awarded competitively › Academic
-